Skip to main content
Clinical Trials/NCT02727504
NCT02727504
Completed
Not Applicable

Low Flow Low Gradient Aortic Stenosis Relevance of the (re)Search for a Contractile Reserve

Rennes University Hospital1 site in 1 country86 target enrollmentMay 11, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aortic Valve Stenosis
Sponsor
Rennes University Hospital
Enrollment
86
Locations
1
Primary Endpoint
Number of emergent hospitalization for any cardiovascular reason
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Investigators sought to demonstrate that the increase in the stroke volume during a dobutamine stress echocardiography might impact the prognosis of a patient addressed for a low flow low gradient suspected severe aortic valve stenosis.

Registry
clinicaltrials.gov
Start Date
May 11, 2016
End Date
January 6, 2020
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Rennes University Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient from 45 to 90 years old
  • Patient agreeing freely to participate in the study
  • Aortic surface area suspected to be \< 1 cm² or \< 0.6 cms²/m²
  • Low aortic gradient defined by a mean pressure gradient \< 40 mmHg
  • Aortic low flow defined by: a stroke volume indexed \< 35 ml/m2
  • Any contra-indication for the realization of the MRI

Exclusion Criteria

  • Heart rhythm disorders
  • Presence of comorbidity altering the 2-year prognosis of a patient (cancer, terminal renal insufficiency (GFR 30 ml / min / 1,73m2), liver cirrhosis, respiratory insufficiency (VEMS 1 L)
  • Presence of a concomitant valvular heart disease with stenosis or regurgitation \> moderated
  • Persons subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty

Outcomes

Primary Outcomes

Number of emergent hospitalization for any cardiovascular reason

Time Frame: Month 12

Number of death of all cause

Time Frame: Month 12

Secondary Outcomes

  • Death (all causes)(12 months)
  • Emergency Cardiovascular hospitalization(12 months)
  • Change in left ventricular ejection fraction (LVEF), in global longitudinal strain in 2D and or 3D echocardiography(Inclusion, 12 months)
  • Symptoms evolution(Inclusion, 12 months)

Study Sites (1)

Loading locations...

Similar Trials